cytotoxic chemotherapy prior days therapy weeks treatment received previous cancer 
brentuximab vedotin prior treatment bv dose previous bendamustine hypersensitivity received 
weeks therapy prior chemotherapy treatment nitrosourea dose cytotoxic mitomycin radiation 
antibody monoclonal weeks prior therapy treatment study received chemotherapy days 
chemotherapy allowable cancer different prior systemic note study therapy previous 
treatments prior previous cancer discontinued patients weeks therapies received systemic 
radiotherapy prior days chemotherapy treatment brain received previous cranial dose 
